IBDEI0VF ; ; 09-AUG-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,41267,1,3,0)
 ;;=3^Blepharitis,Right Upper Eyelid
 ;;^UTILITY(U,$J,358.3,41267,1,4,0)
 ;;=4^H01.001
 ;;^UTILITY(U,$J,358.3,41267,2)
 ;;=^5004238
 ;;^UTILITY(U,$J,358.3,41268,0)
 ;;=H01.004^^121^1772^5
 ;;^UTILITY(U,$J,358.3,41268,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41268,1,3,0)
 ;;=3^Blepharitis,Left Upper Eyelid
 ;;^UTILITY(U,$J,358.3,41268,1,4,0)
 ;;=4^H01.004
 ;;^UTILITY(U,$J,358.3,41268,2)
 ;;=^5004241
 ;;^UTILITY(U,$J,358.3,41269,0)
 ;;=L71.9^^121^1772^6
 ;;^UTILITY(U,$J,358.3,41269,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41269,1,3,0)
 ;;=3^Rosacea,Unspec
 ;;^UTILITY(U,$J,358.3,41269,1,4,0)
 ;;=4^L71.9
 ;;^UTILITY(U,$J,358.3,41269,2)
 ;;=^5009276
 ;;^UTILITY(U,$J,358.3,41270,0)
 ;;=H04.221^^121^1772^10
 ;;^UTILITY(U,$J,358.3,41270,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41270,1,3,0)
 ;;=3^Epiphora d/t Insuff Drainage,Right 
 ;;^UTILITY(U,$J,358.3,41270,1,4,0)
 ;;=4^H04.221
 ;;^UTILITY(U,$J,358.3,41270,2)
 ;;=^5004491
 ;;^UTILITY(U,$J,358.3,41271,0)
 ;;=H04.222^^121^1772^11
 ;;^UTILITY(U,$J,358.3,41271,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41271,1,3,0)
 ;;=3^Epiphora d/t Insuff Drainage,Left 
 ;;^UTILITY(U,$J,358.3,41271,1,4,0)
 ;;=4^H04.222
 ;;^UTILITY(U,$J,358.3,41271,2)
 ;;=^5004492
 ;;^UTILITY(U,$J,358.3,41272,0)
 ;;=H04.551^^121^1772^12
 ;;^UTILITY(U,$J,358.3,41272,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41272,1,3,0)
 ;;=3^Acquired Stenosis,Right Nasolacrimal Duct
 ;;^UTILITY(U,$J,358.3,41272,1,4,0)
 ;;=4^H04.551
 ;;^UTILITY(U,$J,358.3,41272,2)
 ;;=^5004538
 ;;^UTILITY(U,$J,358.3,41273,0)
 ;;=H04.552^^121^1772^13
 ;;^UTILITY(U,$J,358.3,41273,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41273,1,3,0)
 ;;=3^Acquired Stenosis,Left Nasolacrimal Duct
 ;;^UTILITY(U,$J,358.3,41273,1,4,0)
 ;;=4^H04.552
 ;;^UTILITY(U,$J,358.3,41273,2)
 ;;=^5004539
 ;;^UTILITY(U,$J,358.3,41274,0)
 ;;=D23.11^^121^1772^14
 ;;^UTILITY(U,$J,358.3,41274,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41274,1,3,0)
 ;;=3^Benign Neop Skin,Right Eyelid
 ;;^UTILITY(U,$J,358.3,41274,1,4,0)
 ;;=4^D23.11
 ;;^UTILITY(U,$J,358.3,41274,2)
 ;;=^5002061
 ;;^UTILITY(U,$J,358.3,41275,0)
 ;;=D23.12^^121^1772^15
 ;;^UTILITY(U,$J,358.3,41275,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41275,1,3,0)
 ;;=3^Benign Neop Skin,Left Eyelid
 ;;^UTILITY(U,$J,358.3,41275,1,4,0)
 ;;=4^D23.12
 ;;^UTILITY(U,$J,358.3,41275,2)
 ;;=^5002062
 ;;^UTILITY(U,$J,358.3,41276,0)
 ;;=C44.102^^121^1772^16
 ;;^UTILITY(U,$J,358.3,41276,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41276,1,3,0)
 ;;=3^Malig Neop Skin,Right Eyelid
 ;;^UTILITY(U,$J,358.3,41276,1,4,0)
 ;;=4^C44.102
 ;;^UTILITY(U,$J,358.3,41276,2)
 ;;=^5001017
 ;;^UTILITY(U,$J,358.3,41277,0)
 ;;=C44.109^^121^1772^17
 ;;^UTILITY(U,$J,358.3,41277,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41277,1,3,0)
 ;;=3^Malig Neop Skin,Left Eyelid
 ;;^UTILITY(U,$J,358.3,41277,1,4,0)
 ;;=4^C44.109
 ;;^UTILITY(U,$J,358.3,41277,2)
 ;;=^5001018
 ;;^UTILITY(U,$J,358.3,41278,0)
 ;;=C44.112^^121^1772^18
 ;;^UTILITY(U,$J,358.3,41278,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41278,1,3,0)
 ;;=3^BCC Neop Skin,Right Eyelid
 ;;^UTILITY(U,$J,358.3,41278,1,4,0)
 ;;=4^C44.112
 ;;^UTILITY(U,$J,358.3,41278,2)
 ;;=^5001020
 ;;^UTILITY(U,$J,358.3,41279,0)
 ;;=C44.119^^121^1772^19
 ;;^UTILITY(U,$J,358.3,41279,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41279,1,3,0)
 ;;=3^BCC Neop Skin,Left Eyelid
 ;;^UTILITY(U,$J,358.3,41279,1,4,0)
 ;;=4^C44.119
 ;;^UTILITY(U,$J,358.3,41279,2)
 ;;=^5001021
 ;;^UTILITY(U,$J,358.3,41280,0)
 ;;=C44.122^^121^1772^20
 ;;^UTILITY(U,$J,358.3,41280,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41280,1,3,0)
 ;;=3^SCC Neop Skin,Right Eyelid
 ;;^UTILITY(U,$J,358.3,41280,1,4,0)
 ;;=4^C44.122
 ;;^UTILITY(U,$J,358.3,41280,2)
 ;;=^5001023
 ;;^UTILITY(U,$J,358.3,41281,0)
 ;;=C44.129^^121^1772^21
 ;;^UTILITY(U,$J,358.3,41281,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41281,1,3,0)
 ;;=3^SCC Neop Skin,Left Eyelid
 ;;^UTILITY(U,$J,358.3,41281,1,4,0)
 ;;=4^C44.129
 ;;^UTILITY(U,$J,358.3,41281,2)
 ;;=^5001024
 ;;^UTILITY(U,$J,358.3,41282,0)
 ;;=H04.211^^121^1772^7
 ;;^UTILITY(U,$J,358.3,41282,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41282,1,3,0)
 ;;=3^Epiphora d/t Excessive Lacrimation,Right
 ;;^UTILITY(U,$J,358.3,41282,1,4,0)
 ;;=4^H04.211
 ;;^UTILITY(U,$J,358.3,41282,2)
 ;;=^5004487
 ;;^UTILITY(U,$J,358.3,41283,0)
 ;;=H04.212^^121^1772^8
 ;;^UTILITY(U,$J,358.3,41283,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41283,1,3,0)
 ;;=3^Epiphora d/t Excessive Lacrimation,Left
 ;;^UTILITY(U,$J,358.3,41283,1,4,0)
 ;;=4^H04.212
 ;;^UTILITY(U,$J,358.3,41283,2)
 ;;=^5004488
 ;;^UTILITY(U,$J,358.3,41284,0)
 ;;=H04.213^^121^1772^9
 ;;^UTILITY(U,$J,358.3,41284,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41284,1,3,0)
 ;;=3^Epiphora d/t Excessive Lacrimation,Bilateral
 ;;^UTILITY(U,$J,358.3,41284,1,4,0)
 ;;=4^H04.213
 ;;^UTILITY(U,$J,358.3,41284,2)
 ;;=^5004489
 ;;^UTILITY(U,$J,358.3,41285,0)
 ;;=H52.13^^121^1773^1
 ;;^UTILITY(U,$J,358.3,41285,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41285,1,3,0)
 ;;=3^Myopia,Bilateral
 ;;^UTILITY(U,$J,358.3,41285,1,4,0)
 ;;=4^H52.13
 ;;^UTILITY(U,$J,358.3,41285,2)
 ;;=^5006266
 ;;^UTILITY(U,$J,358.3,41286,0)
 ;;=H52.03^^121^1773^2
 ;;^UTILITY(U,$J,358.3,41286,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41286,1,3,0)
 ;;=3^Hypermetropia,Bilateral
 ;;^UTILITY(U,$J,358.3,41286,1,4,0)
 ;;=4^H52.03
 ;;^UTILITY(U,$J,358.3,41286,2)
 ;;=^5006262
 ;;^UTILITY(U,$J,358.3,41287,0)
 ;;=H52.203^^121^1773^3
 ;;^UTILITY(U,$J,358.3,41287,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41287,1,3,0)
 ;;=3^Astigmatism,Bilateral
 ;;^UTILITY(U,$J,358.3,41287,1,4,0)
 ;;=4^H52.203
 ;;^UTILITY(U,$J,358.3,41287,2)
 ;;=^5006269
 ;;^UTILITY(U,$J,358.3,41288,0)
 ;;=H52.4^^121^1773^4
 ;;^UTILITY(U,$J,358.3,41288,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41288,1,3,0)
 ;;=3^Presbyopia
 ;;^UTILITY(U,$J,358.3,41288,1,4,0)
 ;;=4^H52.4
 ;;^UTILITY(U,$J,358.3,41288,2)
 ;;=^98095
 ;;^UTILITY(U,$J,358.3,41289,0)
 ;;=H25.11^^121^1773^5
 ;;^UTILITY(U,$J,358.3,41289,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41289,1,3,0)
 ;;=3^Cataract,Nuclear,Right Eye
 ;;^UTILITY(U,$J,358.3,41289,1,4,0)
 ;;=4^H25.11
 ;;^UTILITY(U,$J,358.3,41289,2)
 ;;=^5005284
 ;;^UTILITY(U,$J,358.3,41290,0)
 ;;=H25.12^^121^1773^6
 ;;^UTILITY(U,$J,358.3,41290,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41290,1,3,0)
 ;;=3^Cataract,Nuclear,Left Eye
 ;;^UTILITY(U,$J,358.3,41290,1,4,0)
 ;;=4^H25.12
 ;;^UTILITY(U,$J,358.3,41290,2)
 ;;=^5005285
 ;;^UTILITY(U,$J,358.3,41291,0)
 ;;=Z98.49^^121^1773^7
 ;;^UTILITY(U,$J,358.3,41291,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41291,1,3,0)
 ;;=3^Cataract Extraction Status,Unspec Eye
 ;;^UTILITY(U,$J,358.3,41291,1,4,0)
 ;;=4^Z98.49
 ;;^UTILITY(U,$J,358.3,41291,2)
 ;;=^5063739
 ;;^UTILITY(U,$J,358.3,41292,0)
 ;;=H04.123^^121^1773^8
 ;;^UTILITY(U,$J,358.3,41292,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41292,1,3,0)
 ;;=3^Dry Eye Syndrome,Bilateral Lacrimal Glands
 ;;^UTILITY(U,$J,358.3,41292,1,4,0)
 ;;=4^H04.123
 ;;^UTILITY(U,$J,358.3,41292,2)
 ;;=^5004465
 ;;^UTILITY(U,$J,358.3,41293,0)
 ;;=H01.009^^121^1773^9
 ;;^UTILITY(U,$J,358.3,41293,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41293,1,3,0)
 ;;=3^Blepharitis,Unspec
 ;;^UTILITY(U,$J,358.3,41293,1,4,0)
 ;;=4^H01.009
 ;;^UTILITY(U,$J,358.3,41293,2)
 ;;=^5133381
 ;;^UTILITY(U,$J,358.3,41294,0)
 ;;=H40.023^^121^1773^10
 ;;^UTILITY(U,$J,358.3,41294,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41294,1,3,0)
 ;;=3^Open Angle w/ Borderline Findings,High Risk,Bilateral
 ;;^UTILITY(U,$J,358.3,41294,1,4,0)
 ;;=4^H40.023
 ;;^UTILITY(U,$J,358.3,41294,2)
 ;;=^5005730
 ;;^UTILITY(U,$J,358.3,41295,0)
 ;;=H40.053^^121^1773^11
 ;;^UTILITY(U,$J,358.3,41295,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41295,1,3,0)
 ;;=3^Ocular Hypertension,Bilateral
 ;;^UTILITY(U,$J,358.3,41295,1,4,0)
 ;;=4^H40.053
 ;;^UTILITY(U,$J,358.3,41295,2)
 ;;=^5005742
 ;;^UTILITY(U,$J,358.3,41296,0)
 ;;=H40.11X3^^121^1773^12
 ;;^UTILITY(U,$J,358.3,41296,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41296,1,3,0)
 ;;=3^Primary Open-Angle Glaucoma,Severe Stage
 ;;^UTILITY(U,$J,358.3,41296,1,4,0)
 ;;=4^H40.11X3
 ;;^UTILITY(U,$J,358.3,41296,2)
 ;;=^5005756
 ;;^UTILITY(U,$J,358.3,41297,0)
 ;;=H35.31^^121^1773^13
 ;;^UTILITY(U,$J,358.3,41297,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41297,1,3,0)
 ;;=3^Nonexudative Age-Related Macular Degeneration
 ;;^UTILITY(U,$J,358.3,41297,1,4,0)
 ;;=4^H35.31
 ;;^UTILITY(U,$J,358.3,41297,2)
 ;;=^5005647
 ;;^UTILITY(U,$J,358.3,41298,0)
 ;;=H35.32^^121^1773^14
 ;;^UTILITY(U,$J,358.3,41298,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41298,1,3,0)
 ;;=3^Exudative Age-Related Macular Degeneration
 ;;^UTILITY(U,$J,358.3,41298,1,4,0)
 ;;=4^H35.32
 ;;^UTILITY(U,$J,358.3,41298,2)
 ;;=^5005648
 ;;^UTILITY(U,$J,358.3,41299,0)
 ;;=E11.9^^121^1773^15
 ;;^UTILITY(U,$J,358.3,41299,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41299,1,3,0)
 ;;=3^DM Type 2 w/o Complications
 ;;^UTILITY(U,$J,358.3,41299,1,4,0)
 ;;=4^E11.9
 ;;^UTILITY(U,$J,358.3,41299,2)
 ;;=^5002666
 ;;^UTILITY(U,$J,358.3,41300,0)
 ;;=E11.39^^121^1773^16
 ;;^UTILITY(U,$J,358.3,41300,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41300,1,3,0)
 ;;=3^DM Type 2 w/ Ophthalmic Complications
 ;;^UTILITY(U,$J,358.3,41300,1,4,0)
 ;;=4^E11.39
 ;;^UTILITY(U,$J,358.3,41300,2)
 ;;=^5002643
 ;;^UTILITY(U,$J,358.3,41301,0)
 ;;=E11.329^^121^1773^17
 ;;^UTILITY(U,$J,358.3,41301,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41301,1,3,0)
 ;;=3^DM Type 2 w/ Mild NPDR w/o Macular Edema
 ;;^UTILITY(U,$J,358.3,41301,1,4,0)
 ;;=4^E11.329
 ;;^UTILITY(U,$J,358.3,41301,2)
 ;;=^5002635
 ;;^UTILITY(U,$J,358.3,41302,0)
 ;;=E11.339^^121^1773^18
 ;;^UTILITY(U,$J,358.3,41302,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41302,1,3,0)
 ;;=3^DM Type 2 w/ Moderate NPDR w/o Macular Edema
 ;;^UTILITY(U,$J,358.3,41302,1,4,0)
 ;;=4^E11.339
